Well-Known Genus, Novel Method: A Post-Amgen Framework for Written Description & Enablement

Key Takeaways: Recent Federal Circuit decision draws a meaningful distinction between patents that claim a broad genus as the invention itself and those that claim a novel therapeutic method using a well‑known genus, signaling that method‑of‑use claims tied to specific treatments may face a narrower written‑description and enablement burden.

Continue reading

J. Craig Venter, genomics pioneer, dies at 79

La Jolla, California—April 29, 2026—The J. Craig Venter Institute (JCVI) announced that J. Craig Venter, Ph.D., the Institute’s founder, board chair, and chief executive officer, died today in San Diego following a brief hospitalization for unexpected side effects that arose from treatment of recently diagnosed cancer.

Dr. Venter was a visionary scientific leader whose work helped define modern genomics and launch the field of synthetic biology. He drove scientific and technological change by building interdisciplinary teams, pushing for bold ideas and faster methods, and insisting that discovery should translate into real-world impact. He was also a fierce advocate for robust federal science funding and for partnerships that accelerate progress across government, academia, and industry.Continue reading

7 Health Sciences faculty and staff members receive Convergence Awards

The annual awards are one of the university’s highest recognitions for interdisciplinary research achievement and honor the faculty, staff and external partners whose work exemplifies the U of A’s commitment to inquiry, innovation and societal impact. The recognition program, which is hosted by the Office of Research and Partnerships, highlights those advancing transformative research and creative activity across disciplines, sectors and communities.Continue reading